The QualityStocks Daily Friday, February 8th, 2019

Today's Top 3 StockMarketWatch

SmallCapVoice (NGTF) +79.66%

StockMarketWatch (EGAN) +47.72%

Trading Concepts (COTY) +32.15%

The QualityStocks Daily Stock List

Timberline Resources Corp. (TLRS)

InvestorsHub, MarketWatch, and Gold Investment Letter reported on Timberline Resources Corp. (TLRS), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

Timberline Resources Corp. is a gold exploration and development company. Its operational focus is the State of Nevada. The Company’s flagship Talapoosa Project is a partially permitted, open-pit, heap leach gold project with low capital and operating costs and strong economics. Additionally, its exploration efforts have been centered on its 23 square-mile Eureka land package. This is one of the largest remaining undeveloped gold properties in Nevada. Timberline Resources is headquartered in Coeur d’Alene, Idaho.

The Company entered into a transaction with Gunpoint Exploration Ltd. on March 17, 2015. Timberline Resources acquired the option to purchase 100 percent of the Talapoosa project, positioned in Lyon County, Nevada. The Talapoosa property is a low-sulphidation gold/silver property in the Walker Lane gold trend of western Nevada, roughly 45 kilometers east of Reno.

Talapoosa highlights include an NI 43-101 resource consisting 1,012,802 oz gold (M&I); 233,532 oz gold (Inferred). Furthermore, highlights include near-surface oxide gold ounces totaling 162,581 oz (M&I); 47,745 oz (Inferred).

Talapoosa has well-established infrastructure. The Talapoosa project in Lyon County is where the Company has completed and disclosed a positive Preliminary Economic Assessment (PEA).

Concerning the Eureka land package, it includes Timberline’s Lookout Mountain project and a pipeline of earlier-stage projects, which feature past gold production, historic gold estimates, and/or drill-indicated gold mineralization. Eureka is on the south end of Nevada’s Battle Mountain/Eureka Trend.

At Eureka, Timberline Resources continues to advance its Lookout Mountain and Windfall project areas. In 2012, the Company purchased a large block of patented and unpatented mining claims. These comprise chiefly the entire Seven Troughs gold mining district near Lovelock in Pershing County, Nevada.

The purchased property package encompasses 4,100 acres. It consists of 64 patented and 238 unpatented lode mining claims, all which are under a long-term lease agreement, along with 162 additional unpatented lode mining claims.

Recently, Timberline Resources announced consolidated financial results for its first Fiscal Year (FY) 2018 quarter ended December 31, 2017. The Company reported a consolidated Net Loss of $0.3 million for the quarter ended December 31, 2017. This includes exploration expenditures of $26,000.

Timberline Resources completed a private placement during the quarter. The Company continues to seek capital for the advancement of the Talapoosa gold and silver project. It expects, subject to having sufficient capital, to continue to advance the Talapoosa project toward a pre-feasibility study and further development.

Timberline Resources Corp. (TLRS), closed Friday's trading session at $0.08836, up 14.90%, on 1,400 volume with 4 trades. The average volume for the last 3 months is 34,673 and the stock's 52-week low/high is $0.00009/$0.23.

chart

American Cannabis Company, Inc. (AMMJ)

Cannabis Financial Network News, Stock News Now, Wealth Insider Alert, Market Intelligence Central, Wall Street Daily, Promotion Stock Secrets, CFN Media Group, The Street, Marketbeat.com, and TheOTCInvestor reported on American Cannabis Company, Inc. (AMMJ), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

OTCQB-listed, American Cannabis Company, Inc. is a full-service Business-to-Business (B2B) consulting solutions provider. It is also a seller of ancillary products to the cannabis industry. American Cannabis provides end-to-end solutions to existing and ambitious participants in the cannabis industry. The Company supports its clients from concept to creation, commercialization and continuing operations. American Cannabis Company has its corporate headquarters in Denver, Colorado.

American Cannabis Company provides complete consulting management and products solutions to the regulated cannabis markets. It uses its industry expertise to provide business planning and market assessment services, assist state licensing procurement, create business infrastructure, and establish operational best practices.

The Company has its proprietary product named SoHum Living Soils™. SoHum Living Soils™ is a proprietary "just add water" growing medium. It contains 100 percent natural ingredients.

SoHum Living Soils™ provides the plant a total buffet of macro/micro nutrients to attain genetic optimization of the cannabis plant. SoHum Living Soils® won the 2017 High Times STASH award for "Best Potting Mix."

Moreover, American Cannabis owns The Cultivation Cube™, and The High Density Cultivation System™. These are proprietary cultivation products.

Regarding Products, American Cannabis provides a comprehensive organic grow system, retail solutions (the Satchel™), and grow components. It also provides group purchasing discounts for supplies.

The Satchel is a child-proof, tamper-proof vessel for dispensaries. The Satchel™ may be used by dispensaries to assemble orders and ensure the proper post sale handling of cannabis per each State's legislation.

Concerning Consulting, the Company provides application support, business planning, site selection, and regulatory compliance, among other services. Regarding Management, American Cannabis provides yield analysis, staffing, business coaching, and staff training and education, and more.

In early January 2018, American Cannabis Company announced that it secured a consulting contract with California City Cannabis Company in the State of California. In association with the consulting agreement, it will acquire an equity stake in California City’s project that is now non-operational and in the development stage.

As proposed, California City has plans to build a cannabis business park in California City, California. The plans for the park include a total of 20 to 25 acres of land set aside for development, and the potential hosting of future extraction, cultivation, as well as distribution businesses.

Recently, American Cannabis Company announced that it secured a consulting contract with Cloud 9 Apothecary in California. In association with the consulting agreement, it will acquire an equity stake in Cloud 9’s project that is presently non-operational and in the development stage.

The project will be built-out and completed in Desert Springs, California. It will consist of a closed-loop greenhouse containing a 22,000 square foot canopy of premium cannabis cultivars.

American Cannabis Company, Inc. (AMMJ), closed Friday's trading session at $0.45, up 4.65%, on 105,150 volume with 67 trades. The average volume for the last 3 months is 119,809 and the stock's 52-week low/high is $0.219/$1.279.

chart

Lexington Biosciences, Inc. (LXGTF)

Tech Stock Insider, MarketWatch, and InvestorsHub reported on Lexington Biosciences, Inc. (LXGTF), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

A medical device company, Lexington Biosciences, Inc. is developing the HeartSentry. This is a new non-invasive diagnostic device to measure and monitor cardiovascular health through assessing the function of a person's vascular endothelium. This is the essential innermost lining of a person's cardiovascular system. The Company’s objective is to become a leader in the development of clinical grade cardiovascular self-measurement solutions for home and clinical use.

Lexington Biosciences is engaged with the US FDA (Food and Drug Administration) and other regulatory agencies on the required product approvals for the HeartSentry. Lexington Biosciences has offices in Vancouver, British Columbia; and Reno, Nevada.

HeartSentry targets the fast growing self-measurement medical device sector. The design of the HeartSentry unit is to use Bluetooth and Cloud technology to provide up-to-date and accurate readings of an individual’s complete cardiovascular health via electronic monitoring for risk-assessment and treatment effectiveness targeting the prevention of heart attack and stroke.

HeartSentry is the Company’s flagship, and first device currently advancing to commercial deployment. Lexington Biosciences earlier announced delivery of its first order of HeartSentry devices scheduled for clinical trials.

The HeartSentry core technology underwent development at the University of California Berkeley over a fifteen-year research and development (R&D) period involving manifold research studies and product iterations resulting in a portfolio of numerous pending and issued patents licensed to Lexington Biosciences.

The Company’s goal is to make HeartSentry accurate, fast, and cost effective so it can become the standard of care for cardiologists, general practitioners, and ultimately patients for first line evaluation of a person's cardiovascular health.

Lexington Biosciences announced in late 2017 the engagement of San Francisco Bay Area-based Diablo Clinical Research to conduct its HeartSentry pilot clinical studies. Last month, Lexington Biosciences announced the start of its clinical trial and first patient enrolment.  The design of the clinical studies is to measure the safety and effectiveness of the HeartSentry technology for cardiovascular health diagnosis.

Earlier this month, Lexington Biosciences provided an early update of its clinical trial and patient enrolment. The team at Diablo Clinical Research, site of the investigative study, advised Lexington that five patients have now been successfully enrolled and admitted to the program. They have undergone the first series of tests with HeartSentry. Under the leadership of Dr. Geoff Tison, M.D. M.P.H., initial results indicate the device is functioning as designed with quantifiable results.

Lexington Biosciences, Inc. (LXGTF), closed Friday's trading session at $0.09124, up 10.86%, on 31,448 volume with 7 trades. The average volume for the last 3 months is 54,132 and the stock's 52-week low/high is $0.0482/$0.418.

chart

Future Farm Technologies, Inc. (FFRMF)

Stockhouse, Morningstar, Barchart, Weed Newswire, OTC Markets, InvestorsHub, MarketWatch, MarketNewsUpdates, and 4-Traders reported on Future Farm Technologies, Inc. (FFRMF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Future Farm Technologies, Inc.’s business model includes developing and acquiring technologies that will position it as a leader in the development of Controlled Environment Agriculture (CEA) for the global production of diverse types of plants, with a concentration on cannabis. The Company has projects across North America. This includes California, Florida, and Maryland.

Future Farm Technologies is based in Vancouver, British Columbia. The Company lists on the OTC Markets Group’s OTCQX.

Future Farm Technologies provides scalable, indoor CEA systems that use minimal land, water and energy regardless of climate, location or time of year. These systems are customized to grow an abundance of crops close to consumers.

The Company also holds an exclusive worldwide license to use a patented vertical farming technology that, when compared to traditional plant production methods, produces yields up to 10 times greater per square foot of land. Future Farm also uses a leading cannabis oil extraction technology, which enables it to process 20lbs/hour of cannabis plant to yield about 908 grams/hour of oil.

Future Farm Technologies also designs and distributes LED lighting solutions using the COB and MCOB technology. The Company earlier acquired the exclusive right to use a patented, augmented reality (AR) technology in the cannabis industry. Future Farm will work with its partner to merge AR and ad-tech with the cannabis industry through the CannaCube Live™ platform.

Future Farm Technologies earlier this year signed a building lease for its Industrial Hemp CBD Oil production and propagation in Maine. It entered into a lease agreement for an initial 12,960 sq. ft. of space in a 60,000 sq. ft. building, with an option to expand and/or purchase the building.

Future Farm also closed on the purchase of a 15,000-sq. ft. building in Providence, Rhode Island. The building is in an M-1 zone that legally permits the cultivation of cannabis by right.

Yesterday, Future Farm Technologies announced the hiring of Mr. Nathan Gray to provide professional consulting services for industrial hemp cultivation and processing operations and management. Future Farm has effected additional operational procedures as part of the Company’s continuing efforts to be the largest hemp cultivator and CBD producer in New England.

Under Mr. Gray’s leadership, Future Farm’s estimation is that its Maine farms will produce roughly 26,000 pounds of biomass in 2018. The expectation is that this amount will increase to 200,000 pounds in 2019. Costs associated with biomass and seed projections are estimated to be $1M-$1.5M per year.

Future Farm Technologies, Inc. (FFRMF), closed Friday's trading session at $0.215, up 2.38%, on 499,023 volume with 189 trades. The average volume for the last 3 months is 362,463 and the stock's 52-week low/high is $0.129/$0.790.

chart

HedgePath Pharmaceuticals, Inc. (HPPI)

MarketWatch, InvestorsHub, BUYINS.NET, and Stockhouse reported earlier on HedgePath Pharmaceuticals, Inc. (HPPI), and today we report on the Company, here at the QualityStocks Daily Newsletter.

HedgePath Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It discovers, develops, and plans to commercialize front-line therapeutics for patients with cancer. The Company is looking to repurpose the Food and Drug Administration (FDA) approved antifungal pharmaceutical itraconazole as a potential treatment for cancer. HedgePath Pharmaceuticals is headquartered in Tampa, Florida. The Company lists on the OTCQB.

HedgePath Pharmaceuticals is the exclusive U.S. licensee of a patented formulation of itraconazole, named SUBA-Itraconazole. Clinical studies have shown it to have more bioavailability than generic itraconazole.

The Hedgehog signaling pathway is a major regulator of cellular processes in vertebrates. This includes cell differentiation, tissue polarity, as well as cell proliferation.

The Company believes (based on published research) that inhibiting the Hedgehog pathway could delay or possibly prevent the development of certain cancers in humans. Leveraging research undertaken by key investigators in the field, HedgePath’s plan is to explore the effectiveness of SUBA-Itraconazole as an anti-cancer agent and to pursue its potential commercialization.

The design of “SUBA technology” (which stands for “Super Bioavailability”) is to improve the bioavailability of orally administered drugs that are poorly soluble. SUBA-Itraconazole is a patented formulation developed by Mayne Pharma. It has improved absorption and substantially reduced variability in comparison to generic itraconazole.

Last month, HedgePath Pharmaceuticals announced that it signed an exclusive option agreement with the University of Connecticut (UConn) related to patents and patent applications covering certain chemical analogues of the FDA-approved anti-fungal drug itraconazole.

The option agreement went into effect on August 1, 2018. It is for an exclusive option period of six months that is extendible to twelve months.  The optioned field of use includes all therapeutic, prophylactic, and diagnostic uses for cancerous and non-cancerous cell proliferation disorders in humans.

This week, HedgePath Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) confirmed the Company's present clinical and regulatory pathway related to HedgePath’s SUBA™-Itraconazole as a treatment for Basal Cell Carcinoma (BCC) in patients with Basal Cell Carcinoma Nevus Syndrome (BCCNS, or Gorlin Syndrome). The  FDA's positive feedback was received at the Company’s earlier announced July 23, 2018 Type-C Meeting with the FDA. It  was confirmed in minutes of the meeting received by HedgePath from the FDA.    

HedgePath Pharmaceuticals, Inc. (HPPI), closed Friday's trading session at $0.08, up 2.56%, on 986 volume with 1 trade. The average volume for the last 3 months is 14,460 and the stock's 52-week low/high is $0.0402/$0.375.

chart

Patriot Gold Corp. (PGOL)

Real Pennies, OtcWizard, Gold Investment Letter, and Standout Stocks reported earlier on Patriot Gold Corp. (PGOL), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Patriot Gold Corp. is a precious metals exploration and production company. Its mission is to discover and develop significant gold and silver assets in Arizona and Nevada. The Company currently holds a portfolio of four projects. These are the Moss project in Arizona and three in Nevada (Bruner, Vernal, and Windy Peak). Patriot Gold is headquartered in Las Vegas, Nevada.

Patriot holds a 3 percent royalty in the Moss Mine in Arizona, an interest in the Bruner gold project in Nevada, and a 100 percent interest in the Vernal and Windy Peak projects in Nevada.

The Moss Mine Project is within the historic Oatman District, 10 miles east of Bullhead City, Arizona and roughly 70 miles southeast of Las Vegas. Northern Vertex Mining Corp. owns the Moss Mine.

The Vernal gold project is in its early stage. This property is roughly 140 miles east-southeast of Reno, Nevada, on the west side of the Shoshone Mountains. The property consists of 12 unpatented mining claims (240 acres).

Patriot Gold owns a 2 percent royalty in the Bruner gold project. The Bruner gold project property is about 130 miles east-southeast of Reno, Nevada. It is at the northern end of the Paradise Range and 45 miles northwest of the Round Mountain Mine.  Canamex Resources Corp. owns the Bruner gold project.

The Windy Peak Gold Project comprises 79 unpatented mineral claims in the Fairview mining district in southwest Nevada. Windy Peak is easily accessed. It is around 45 miles southeast of Fallon and 6 miles from Middlegate.

The Bruner and Vernal gold projects are in Nevada's Walker Lane, which hosts many major deposits. These include the Goldfield (more than 5 million ounces of post production and present reserves) and the Comstock (more than 8 million ounces).

This past March, Patriot Gold reported that the Moss Mine, owned by Northern Vertex Mining, entered production with the announcement of its first gold pour. In addition, Vertex Mining announced funding of $2,000,000 CDN for continued exploration and a commitment of up to $100 million USD for continued acquisition and development.

Furthermore, in March, Patriot Gold reported that it is exploring its 100 percent-owned Windy Peak gold project in Nevada, and announced permitting is in place for a drilling program. The Company identified a number of drilling targets.

Patriot Gold Corp. (PGOL), closed Friday's trading session at $0.08026, up 30.93%, on 180 volume with 1 trade. The average volume for the last 3 months is 28,590 and the stock's 52-week low/high is $0.0438/$0.147.

chart

Innovus Pharmaceuticals, Inc. (INNV)

HotTopPennyStocks, PennyPickAlerts, PHUB News, Wall Street Mover, StockMarketQuote, Fortune Stock Alerts, Penny Stock Bets, StockMister, 1-2-3 Stock Alerts, DSR News, Penny Stock Hub, BUYINS.NET, Promotion Stock Secrets, TopPennyStockMovers, SeeThruEquityResearch, Penny Stock Circle, and OTPicks reported earlier on Innovus Pharmaceuticals, Inc. (INNV), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.

Innovus Pharmaceuticals, Inc. is a developing Over-The-Counter (OTC) consumer goods and specialty pharmaceutical enterprise. The Company engages in the commercialization, licensing, and development of safe and effective non-prescription medicine and consumer care products to improve men’s and women’s health and vitality and respiratory diseases. Innovus Pharmaceuticals is based in San Diego, California. The Company lists on the OTCQB.

Innovus generates revenues from its lead products BTH® Testosterone Booster; BTH® Human Growth Agent; Zestra® for female arousal and EjectDelay® for premature ejaculation. The Company has an additional five marketed products. These include Sensum+® for the indication of decreased penile sensitivity; Zestra Glide®; Vesele® for promoting sexual health; RecalMax™ for promoting brain and cognitive health; Androferti® (in the U.S. and Canada) to support overall male reproductive health and sperm quality; BTH Vision Formula; BTH Blood Sugar, among others and eventually FlutiCare™ OTC for Allergic Rhinitis, if its Abbreviated New Drug Application (ANDA) receives approval by the FDA.

Last year, Innovus Pharmaceuticals launched AllerVarx™ in the U.S. AllerVarx™ is a clinically proven supplement, scientifically formulated for the relief of allergy symptoms. AllerVarx™, selling in Europe under the brand name Lertal®, is a product Innovus exclusively in-licensed for the U.S. and Canada from NTC s.r.l., which is an Italian company.

Innovus Pharmaceuticals has plans to enter the oncology supportive care OTC market with an exclusive license to two GRAS (Generally Recognized As Safe by the U.S. FDA)-listed compounds, thymol and carvacrol, for cachexia and muscle growth and repair, from the University of Iowa Research Foundation.

Innovus Pharmaceuticals announced in 2018 that the FDA cleared the Company’s GlucoGorx™ Glucose Monitoring Test Kit, which includes a glucose meter, test strips and lancet device (GlucoGorx™ Kit) under the 510(k) filing of its manufacturing partner, ACON Laboratories, Inc. Innovus will offer the GlucoGorx™ Kit, which will provide highly sensitive glucose level testing results within four seconds, to its customers who buy its GlucoGorx™ clinical glucose supplement.

Last month, Innovus Pharmaceuticals announced that it entered into a pilot program with the nationwide pharmaceutical chain CVS Pharmacy, Inc. (CVS), a subsidiary of CVS Health Corp (CVS), to sell Innovus’ product Androferti®. If successful, the CVS pilot program could lead to the national pharmacy stocking and selling Androferti® on a scalable level across the nation and could expand to add more Innovus products.

Last week, Innovus Pharmaceuticals announced the filing by the Company for regulatory approval in Canada for its Xyralid® Suppositories drug for the relief of hemorrhoidal swelling; Beyond Human® Testosterone to promote and maintain testosterone levels in men; and RecalMax™ for cognitive health and mental sharpness. The regulatory approval process for the three products could take up to 210 days for approval depending on the application.

In addition, last week, Innovus Pharmaceuticals announced that it entered into a purchase agreement with the nationwide retail store chain Showcase, a Canadian company, for its drug Apeaz®, for arthritis pain relief. Apeaz® will be available in Showcase’s 110 stores across the U.S. and Canada and on its www.ShopAtShowcase.com website beginning mid-August 2018.

Innovus Pharmaceuticals, Inc. (INNV), closed Friday's trading session at $0.0559, up 4.49%, on 361,665 volume with 37 trades. The average volume for the last 3 months is 665,463 and the stock's 52-week low/high is $0.044/$0.209.

chart

Chesapeake Gold Corp. (CHPGF)

Stock Orange, Investor Intel, Investors Hangout, Metals Channel, The Street, Stockhouse, Wallmine, YCharts, Mining Stock Valuator, Research Pool, Equities, OTC Markets, Silicon Investor, GuruFocus, Northern Miner, 24hgold, Gold Stock Data, Penny Stock Hub, Capital Cube, Small Cap Network, Barchart, MarketWatch, StockInvest, Wallet Investor, Market Screener, Morningstar, Investors Hub, and 4-Traders reported earlier on Chesapeake Gold Corp. (CHPGF), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.

Chesapeake Gold Corp. centers on the exploration and development of precious metals projects in North America. Its management and technical team have an excellent track record. This team, with Francisco Gold Corp., discovered El Sauzal and Marlin, which are two Goldcorp, Inc. mines in Mexico and Guatemala. OTCQX-listed, Chesapeake Gold is headquartered in Vancouver, British Columbia.

The Company's major project is its 100 percent owned Metates gold deposit. This project is in Durango state, Mexico. Metates is one of the largest undeveloped gold and silver projects in the world. Independent Mining Consultants reported NI 43-101 (National Instrument 43-101) proven and probable reserves of 18.5 million ounces of gold, 526 million ounces of silver, and 4.2 billion pounds of zinc. The metal prices assumed for the reserves are $1,200 per ounce gold and $25 for silver per ounce at a cutoff grade of 0.35 g/t gold equivalent.

Metates has the option to be an initial 30,000 tpd or 60,000 tpd mine that expands to full nameplate capacity. A pre-feasibility study (PFS) by M3 Engineering indicates at the Phase 2 throughput rate of 120,000 tpd, yearly production over 25 years would be 659,000 ounces of gold, 16 million ounces of silver and 143 million pounds of zinc at a gold equivalent cash cost of $490 per ounce, net zinc credits.

Additionally, Chesapeake Gold’s Mexico properties include Yarely, La Gitana, La Cecilia, and Tatatila. Yarely is an emerging diversified camp. Drilling has discovered a large porphyry system. The Company’s U.S. property is Talapoosa. Talapoosa has an open pit resource of 1.2 million ozs of gold and 16 million ozs silver with first-rate exploration upside. Chesapeake’s Guatemala property is El Escorpion.

This past December, Chesapeake Gold provided an update on the exploration work at its 100 percent owned Yarely Project in Sinaloa State and Tatatila Project in Veracruz State, Mexico. A Phase I drill program at Yarely in early 2018 tested three of six known prospects.

The drill results and related exploration activities reported in June of 2018. The drill program was successful in the discovery of a blind copper-molybdenum porphyry system at Loretos, a wide-ranging near-surface polymetallic skarn at Lucy, as well as a high grade gold-silver vein system at Spaniard-Central. The Company also reported on a host of other projects in its December update (https://bit.ly/2MTkpoo).

For 2019 at Yarely, the Goyo prospect will be systematically advanced to the drill stage and also follow-up exploration in several areas showing anomalous stream sediments. Yarely continues to be an emerging, diversified mineralized camp with numerous district scale prospects and the potential for future discoveries.

Chesapeake Gold Corp. (CHPGF), closed Friday's trading session at $1.72, down 1.15%, on 4,290 volume with 14 trades. The average volume for the last 3 months is 11,027 and the stock's 52-week low/high is $1.10/$2.72.

chart

Micromem Technologies, Inc. (MMTIF)

MarketWatch, Penny Stock Tweets, Infront Analytics, Equity Clock, InvestorsHub, SmallCapVoice, Dividend Investor, last10k, Xtremepicks, OurHotStockPicks, GuruFocus, Wallet Investor, Stockhouse, Morningstar, Stock Stars, Trading View, PennyStocks24, Capital Cube, Investors Hangout, and Pink Investing reported earlier on Micromem Technologies, Inc. (MMTIF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Micromem Technologies, Inc. is a leader in viable Sensor Technology and MRAM (Magnetoresistive Random Access Memory). At present, the Company is focused on magnetic sensor applications via its wholly-owned subsidiary, Micromem Applied Sensor Technologies, Inc. (MAST, Inc.). OTCQB-listed, Micromem Technologies is based in Toronto, Ontario. The MAST, Inc. subsidiary is based in New York, New York.

Micromem’s technologies and solutions include surface functionalization of magnetic nanoparticles; nanoparticle detection platforms to sub-ppb detection levels; customized integration of NEMS/MEMS sensor platforms; magnetic sensor solutions; and sensor-based analytical solution platforms. Technologies and solutions also include structural integrity sensors; wireless suib-surface power solutions; asset protection sensor platforms; and energy storage solutions.

Micromem Technologies designs, develops and provides sensors specific to industry needs. The MAST subsidiary centers on developing and marketing the delivery of inventive magnetic sensor applications in industries including Defense, Life Sciences, Automotive, Consumer, and Mining. MAST develops MEMS/NEMS solutions through combining disparate sensor modalities to create solutions for clients’ problems.

MAST works closely with its clients during development to ensure a smooth transfer to their production facility. MAST is not a product company.

Concerning Energy Storage Solutions, MAST, working together with an energy storage company and a top U.S. utility, is providing sensor technology and overall system and product integration management for the practical realization of a new energy storage system. This system will enable lower costs than building new power generating plants.

Pertaining to its Magnetic Nanoparticle Detection Platform, MAST, working with a leader in the oil industry, has developed an instrument that detects breakthrough water in production oil wells through magnetic and optical sensor techniques.

This week, Micromem Technologies, via Micromem Applied Sensor Technologies, Inc. (MAST), announced an update on the status of the ATRA 171 project it has been developing over the last 5 years with its oil company partner, Chevron Corporation (NYSE: CVX). With this agreement, the continuing pilot project is proceeding through on site well evaluation. Also, the commercialization plans for this technology are progressing.

Micromem Technologies, Inc. (MMTIF), closed Friday's trading session at $0.034, up 4.62%, on 446,987 volume with 13 trades. The average volume for the last 3 months is 320,114 and the stock's 52-week low/high is $0.0214/$0.27.

chart

Nautilus Minerals, Inc. (NUSMF)

OTC Markets, PennyStockTweets, Stockhouse, Equities, Marketwired, InvestorsHub, Barchart, Junior Mining Network, The Street, MarketWatch, and YCharts reported previously on Nautilus Minerals, Inc. (NUSMF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Nautilus Minerals, Inc. is the first company to explore the ocean floor for polymetallic Seafloor Massive Sulphide (SMS) deposits. Nautilus is developing a production system utilizing existing technologies adapted from the offshore oil and gas industry, dredging and mining industries to enable the extraction of these high-grade SMS systems on a commercial scale.

Nautilus Minerals has offices in Brisbane, Australia; Canada; and in Kavieng, New Ireland, Papua New Guinea, and Nuku'alofa, Tonga, South Pacific.

A seafloor resource exploration business, Nautilus explores and develops the ocean floor for copper, gold, silver, and zinc SMS deposits. Furthermore, the Company explores for manganese, nickel, copper, and cobalt nodule deposits. Nautilus has its copper-gold project named Solwara 1. It is under development in the territorial waters of Papua New Guinea (PNG).

The Solwara 1 deposit sits on the seafloor at a water depth of about 1600 meters. Solwara 1 contains a copper grade of approximately 7 percent. This compares with land-based copper mines, where the copper grade today averages 0.6 percent.

Gold grades of substantially more than 20 g/tonne have been recorded in some intercepts at Solwara 1. The average grade is roughly 6 g/tonne. Moreover, the Company holds highly prospective exploration acreage in the western Pacific (granted and under application), and in international waters in the Central Pacific.

Nautilus Minerals is currently negotiating the terms of an agreement with arm's length third parties. This would involve the establishment of a new joint venture company (the Vessel JV) to be owned by the third parties and Nautilus’ subsidiary, Nautilus Minerals Niugini Limited (NMN).

The purpose of the Vessel JV would be to fund the acquisition of the Production Support Vessel (PSV) that Nautilus had previously arranged to be obtained through MAC Goliath Pte Ltd (MAC) and the integration expenses of installing the mining equipment on the PSV. The Vessel JV would own and operate the fully integrated PSV.

Yesterday, Nautilus Minerals announced that it and Deep Sea Mining Finance Ltd. agreed to extend the maturity date of the existing secured loan facility that is currently due on February 8, 2019, for 28 days ending on March 8, 2019.

Nautilus continues to seek short and long term funding solutions. This is while assessing its options, including different restructuring options. Negotiations with various third parties continue.

Nautilus Minerals, Inc. (NUSMF), closed Friday's trading session at $0.0467, even for the day, on 107,585 volume with 8 trades. The average volume for the last 3 months is 213,865 and the stock's 52-week low/high is $0.028/$0.3102.

chart

Nutritional High International, Inc. (SPLIF)

Wallet Investor, SECFilings.com News, Marketwired, SmallCapVoice, Daily Marijuana Observer, CFN Media Group, Barchart, Insider Financial, 4-Traders, The Street, and Promotion Stock Secrets reported previously on Nutritional High International, Inc. (SPLIF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Nutritional High International, Inc. centers on developing, manufacturing, and distributing products and nationally recognized brands in the hemp and marijuana-infused products industries. These include edibles and oil extracts for nutritional, medical, and adult recreational use. The Company works exclusively via licensed facilities in jurisdictions where such activity is permitted and regulated by state law. Nutritional High International is based in Toronto, Ontario and the Company lists on the OTCQB.

Pertaining to its Hemp-Infused Products segment, Nutritional High launched the first product in its Active Hemp category under the brand of “Nutritional Traditions”. For this segment, first distribution will focus on California and Colorado by way of cannabis-related retail stores: medical marijuana dispensaries, vape lounges and headshops; and Food Supplement retail stores.

Regarding its Marijuana-Infused Products segment, the Company concentrates on developing, acquiring, and designing Marijuana-Infused Products (MIPs) and Marijuana Concentrate products and brands. With this segment, Nutritional High is establishing operations in Colorado and Illinois. The Company is working to expand into more U.S. States in support of its strategy to establish some of the first nationally-recognized brands for MIPs.

Last month, Nutritional High International announced that it entered into a Letter of Intent (LOI) to purchase a controlling 51 percent interest in Tres Ojos Naturals, LLC d/b/a SolDaze, a limited liability company from Santa Cruz, California. SolDaze produces cannabis infused fruit snacks in California that undergo distribution by Nutritional High’s distributor, Calyx Distributions.

Last week, Nutritional High International reported that effective February 1, 2019, the City of Sacramento Cannabis Policy & Enforcement rescinded local authorization for cannabis manufacturing for Pasa Verde, LLC, a subsidiary of the Company. Without local authorization in place, the California Department of Public Health was required to revoke Pasa Verde’s state temporary manufacturing license.

This does not in any way affect the licensing of Nutritional High International’s distribution operations under Calyx Brands, the temporary-licensed cannabis distribution subsidiary of the Company. Additionally, it has minimal impact on Company operations.

Mr. Jim Frazier, Nutritional High International’s Chief Executive Officer, said, “While we had hoped to maintain the local authorization at FLI Labs NorCal and secure the BOP [Business Operating Permit] early on in the build-out period, this is a minor shift in our operations. We look forward to working with the City on a new BOP, completing the build-out and moving forward with fully compliant manufacturing, production and packaging operations at scale in Sacramento.”

Nutritional High International, Inc. (SPLIF), closed Friday's trading session at $0.225, up 3.21%, on 26,582 volume with 17 trades. The average volume for the last 3 months is 164,816 and the stock's 52-week low/high is $0.098/$0.469.

chart

Petrogress, Inc. (PGAS)

NetworkNewsWire, Penny Stock Tweets, InvestorsHub, MarketWatch, Morningstar, GuruFocus, Wallet Investor, Stockhouse, OilandGas360, Capital Cube, The Street, Barchart, YCharts, Canadian Insider, Corporate Information, Stockopedia, Ceo.ca, Dividend Investor, Investing.com, Simply Wall St, StockInvest.us, Annual Reports, 4-Traders, and last10k reported on Petrogress, Inc. (PGAS), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Petrogress, Inc. is an independent Oil energy and Shipping company listed on the OTC Markets. The Company operates as an integrated basis and specializes in oil exploration, production, trade and sea transportation. It has global operations across Europe, Africa and the Middle East. Petrogress is based in Delaware and New York.

Petrogress operates chiefly as a holding company for its wholly-owned subsidiaries. The Company is in the process of a number of expansion initiatives. Furthermore, Petrogress is building on a vision to emerge as a vertically-aligned, international oil refining, trading and shipping operator.

The Company’s emphasis is on the supply and trade of light petroleum fuel oil, refined oil products, and other petrochemical products to local refineries in West Africa and Mediterranean nations. The physical trading and logistics of petroleum products is Petrogress’ core business.

Petrogress’ operations include Upstream - oil resources and exploration (Petrogress Oil & Gas Energy, Inc.); Midstream – product fleet carriers (Petronav Carriers, LLC); Downstream – processing and refining (J/V PGO & PGL - Ghana); and Marketing – purchases and sales (Petrogress Co. Ltd.).

In March of 2018, Petrogress’ subsidiary, Petrogress Co., Ltd. (PGL), entered into a Partnership Agreement with Platon Gas Oil Ghana. PGL anticipates delivery of 3,000-5,000 metric tons of crude oil each month to Platon’s facilities for storage and processing into varied petroleum products.

Petrogress will participate in refinery expansion plans. With Platon, it will market and distribute the refined petroleum products in Ghana and neighboring countries.

Petrogress’ belief is that the partnership with Platon should increase sales and net profits for the Company. This is while providing assurances of continued transactions and secured sales.

Petrogress also believes that the partnership should provide for significant production upgrading at the refinery, going from present processing capacity of 75,000 barrels per month to 200,000 barrels per month. Furthermore, the Company believes that the partnership should widen its presence in the refining oil sector.

Petrogress, Inc. (PGAS), closed Friday's trading session at $1.36, up 0.74%, on 597 volume with 3 trades. The average volume for the last 3 months is 2,385 and the stock's 52-week low/high is $0.006/$1.70.

chart

Rezolute, Inc. (RZLT)

Spotlight Growth, Emerging Growth, MarketWatch, Dividend Investor, Market Screener, OTC Markets, Simply Wall St, GuruFocus, Street Insider, Investing Online, The Street, Stockopedia, Morningstar, InvestorsHub, 4-Traders, Barchart, last10k, Stockhouse, YCharts and Wallet Investor reported earlier on Rezolute, Inc. (RZLT), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Rezolute, Inc. is a clinical stage biopharmaceutical company headquartered in Louisville, Colorado. It specializes in the development of innovative drug therapies for metabolic and orphan diseases. The Company formerly went by the name AntriaBio, Inc. It changed its corporate name to Rezolute, Inc. in December of 2017. Rezolute’s shares trade on the OTC Markets Group’s OTCQB.

Rezolute is advancing a divers pipeline. This pipeline includes RZ358 (Phase 2). This is an antibody for the ultra-orphan indication of Congenital HyperInsulinism (CHI), with an abbreviated path-to-market strategy. In addition, the pipeline includes AB101 (Phase 1). This is a once-weekly injectable basal insulin with the potential to transform the treatment landscape in diabetes management through reducing the therapeutic burden for patients and improving compliance.

The Company’s pipeline also includes a Plasma Kallikrein Inhibitor (PKI) portfolio with two lead compounds. One is RZ402 targeting Diabetic Macular Edema (DME). The other is RZ602 targeting Hereditary Angioedema (HAE), an orphan indication.

Rezolute and XOMA Corporation have executed a license agreement. The agreement provides Rezolute with the exclusive international rights to develop and commercialize RZ358 (formerly XOMA 358) for Congenital Hyperinsulinism (CHI), an ultra-orphan indication. XOMA is a pioneer in the discovery, development, as well as licensing of therapeutic antibodies.

RZ358 is a first-in-class fully human monoclonal antibody. It counteracts the effects of elevated insulin via allosteric modulation of the insulin receptor. This makes it well-suited as a therapy for severe, persistent hypoglycemia caused by hyperinsulinemic conditions such as CHI.

Last month, Rezolute announced that it entered into a $25 million preferred stock purchase agreement with two pharmaceutical companies that have elected to make a strategic investment in Rezolute. The investors include Handok, Inc., and Genexine, Inc., two premier publicly traded South Korean-based pharmaceutical companies. These two have a collective market capitalization of greater than $1.7 billion. With this agreement, each preferred share is priced at $5.00 and automatically converts into shares of Rezolute’s common stock at an implied per share price of $0.22.

Rezolute’s intention is to use the proceeds from this offering to advance its clinical programs. This includes initiating a Phase 2b clinical study for RZ358 in the U.S. and Europe; completing the required toxicology studies for RZ402 to enable the filing of an IND and initiation of clinical studies; and completing an ongoing Phase 1 study for AB101.

Rezolute, Inc. (RZLT), closed Friday's trading session at $0.24, even for the day. The average volume for the last 3 months is 14,042 and the stock's 52-week low/high is $0.09/$0.83.

chart

THC BioMed Intl. Ltd. (THCBF)

Stockhouse, Market Screener, Marketwired, Investors Hangout, Barchart, MarketWatch, Tip Ranks, Markets and Markets, Marketbeat, Insider Financial, Morningstar, InvestorsHub, YCharts, Wallet Investor, GuruFocus, and TradingView reported earlier on THC BioMed Intl. Ltd. (THCBF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

THC BioMed Intl. Ltd. is an ACMPR (Access to Cannabis for Medical Purposes Regulations) Licensed Producer and Canada's largest supplier of legal Cannabis Genetics. In addition, the Company produces and sells dried and fresh marijuana and cannabis oil for medical purposes. THC currently offers greater than two dozen different genetic strains for sale. The Company has the largest assortment of genetic strains available in Canada for home growers. THC BioMed is based in Kelowna, British Columbia.

On February 6, 2019, the  OTC Markets Group, Inc. (OTCM) announced that THC BioMed Intl Ltd. (OTCQX: THCBF) qualified to trade on the OTCQX® Best Market. THC BioMed upgraded to the OTCQX from the OTCQB® Venture Market.

The Company has its Clone Shipper acquisition. THC BioMed is laying the foundation in preparation for becoming the wholesaler of choice of live clones to the expected home growers' market. The patented design of the Clone Shipper 3.0 containers allows for an LED light to keep the clone in the growing vegetative stage for 12 to 24 hours during shipment. The Company is using the newly designed Clone Shipper 3.0 containers to ship live cannabis plants across Canada.

THC BioMed has created THC2GO Dispensaries. THC, by way of its wholly-owned subsidiary "THC2GO Dispensaries", began the application process to become a cannabis retailer in the Province of Manitoba. Moreover, THC2GO Dispensaries’ intention is to apply for retail outlets in each Canadian province that permits private cannabis retail outlets.

THC BioMed has developed a cannabis beverage that imitates alcohol in that the uplifting and energizing effects of the cannabis is felt by the consumer in a short period of time. The Company believes that this beverage is a solution to a major problem with cannabis beverages and edibles, as present products cause fatigue and drowsiness. Production and sale of the beverage is not currently legal in Canada. It may become legal at a later date. THC BioMed intends to patent the formula.

THC BioMed announced in November 2018 that it received a Cannabis Act and Cannabis Regulations License from Health Canada on November 8, 2018. This is the new license under the Cannabis Act. It allows THC BioMed to grow, produce, as well as sell cannabis products on a large scale under the new regime.

This past December, THC BioMed announced that it made its first shipment of cannabis to the Province of Saskatchewan. The shipment included the Company's bestselling Cannabis strains in dried and pre-rolled forms.

Additionally, because of the high demand for its products, THC completed its fifth shipment of cannabis products to the Province of British Columbia. The shipment included THC BioMed's premium CBD Strain, branded THC CBD, and the Company’s popular Atomical Haze strain.

THC BioMed Intl. Ltd. (THCBF), closed Friday's trading session at $0.341, down 2.57%, on 74,960 volume with 41 trades. The average volume for the last 3 months is 87,765 and the stock's 52-week low/high is $0.1868/$1.58.

chart

The QualityStocks Company Corner

MustGrow Biologics Corp.

The QualityStocks Daily Newsletter would like to spotlight MustGrow Biologics Corp..

MustGrow Biologics Corp. is an agricultural biotech company focused on developing and commercializing its patented technology that is a natural biopesticide and biofertilizer for use as a fertilizer, nematicide, pesticide and fungicide. MustGrow’s novel and proprietary solutions utilize organic components refined from mustard seed to provide high quality, organic pest control to growers facing challenges associated with soil-borne diseases and pests such as nematodes. The company’s technology provides an all-natural, effective, safe and easy-to-use solution for farmers seeking to raise healthy crops without the use of pesticides.

Nematodes, or microscopic worms, are the most numerous multicellular animals on earth. A handful of soil will contain thousands of nematodes, many of which are parasites of insects, plants or animals. Most plant-parasitic nematodes feed on the roots of plants, damaging the root system and reducing the plant’s ability to absorb water and nutrients (http://nnw.fm/Qkz21). For the past 50 years, nematodes have been controlled using chemical nematicides, but the Environmental Protection Agency now restricts or bans many of the chemical formulations.

MustGrow’s technologies provide nematode control that is equal and often superior to synthetic alternatives, resulting in elevated yields and increased returns for the grower. The global economic impact of soil-borne nematodes is estimated at nearly $100 billion in lost crops per year. The American Phytopathological Society (http://nnw.fm/3HGuT), an international nonprofit scientific organization dedicated to the study and control of plant diseases, estimates that plant-pathogenic nematodes are responsible for 14 percent of crop losses worldwide.

MustGrow’s technology refines mustard seeds to concentrate the plant’s natural organic compounds that form Allyl isothiocyanate (“AITC”), which serves the plant as a natural defense system against pests and diseases. As a result, MustGrow’s novel product offers first-class performance, is 100 percent natural, and its fertilizer product is listed for organic use by the Organic Materials Review Institute (“OMRI”) under specifications set by the USDA’s National Organic Program.

MustGrow’s initial technology was a granular pre-plant soil biofumigant and biofertilizer containing the active ingredient AITC, a proven nematicide, fungicide and fertilizer. The company has completed 110 independent third-party field trials on fruit and vegetable crops. As a biofertilizer, MustGrow’s product is registered with Health Canada and the EPA in all U.S. states as OMRI-certified. It is also registered for use as a biopesticide by the EPA in key fruit and vegetable growing U.S. states (except California) and with Health Canada. MustGrow is finalizing a new liquid delivery platform with increased concentration of the same active ingredient (AITC) that can be applied through drip lines to meet the demands of today’s growers.

Results of tests completed to date show that MustGrow continues to provide innovative solutions with broad based applications within agriculture. Validated field trial results include:

  • 100 percent control of root-knot nematodes in strawberry crops as compared to methyl bromide
  • 55 percent tomato crop yield increase
  • 95 percent control of Pythium root rot in lettuce fields
  • 70 percent reduction in Verticillium root severity in cucumbers
  • Market Opportunity

Market Opportunity

MustGrow is also testing the potential application of its technology to the cannabis industry, which is projected to grow to nearly $22 billion in the U.S. by 2020. While there are no uniform guidelines for pesticide use in the cannabis industry, state-by-state regulations in the U.S. do exist which has led to instances of pesticide-tainted cannabis showing up in tested products, leading to recalls and threats of lawsuits. Health Canada recently published regulations for mandatory testing for pesticides in cannabis that are now in effect for all growers. MustGrow’s potential application for cannabis production shows that when its product is used as a pre-plant/pot soil treatment, it may significantly help control many soil-borne diseases, pathogens and pests, including nematodes, fusarium, rhizoctonia, and botrytis (gray mold) that affect the cannabis plant. Cannabis consumers are increasingly demanding organic products free from chemicals and have shown they are willing to pay a premium for high-quality organic cannabis. MustGrow is currently running cannabis soil trials and is seeking Health Canada approval for use of its product on cannabis.

Global crop protection is a multibillion-dollar market that is expected to surge over the next five years. Sales of nematicides are set to grow by 33 percent to $1.43 billion by 2022, while biopesticides are projected to leap by 94 percent to an estimated $9.5 billion by 2022. MustGrow is targeting the global nematicide industry with products that include an innovative pre-plant soil treatment. Solutions for the global biopesticide industry include seed treatment technologies, fungicides and nematicides.

MustGrow’s groundbreaking technologies use novel plant compounds to provide superior crop protection naturally.

Management Team

President and CEO Corey Giasson is an entrepreneur with more than 20 years in the agriculture, potash, oil and gas, mining and real estate industries. Mr. Giasson co-founded Rallyemont Energy Inc., a heavy oil company that successfully identified 140 million barrels of recoverable heavy oil, that was sold in 2013 to Husky Energy. He holds an MBA and bachelor’s degree in agricultural economics from the University of Saskatchewan.

Chairman Brad Munro has 20-plus years as a vice president/investments, with a national venture capital firm where he sourced, invested and managed the activity of over 30 companies and invested $150 million. He has served as a director of over 20 public companies and a greater number of private enterprises. Munro is currently director of Secure Energy Services.

COO Colin Betsky is the previous vice president/BioAg at Novozymes, where he was responsible for the company’s BioAg business worldwide. He holds a bachelor’s degree in agriculture from the University of Saskatchewan and has more than 20 years of experience in agricultural chemicals and biologics.

Director Tom Flow is the founder and current president of The Flowr Corporation (TSX.V: FLWR) and Licensed Producer of cannabis in Canada. He founded and built MedReleaf, Canada’s most profitable Licensed Producer which was later acquired by Aurora Cannabis (TSX: ACB) (NYSE: ACB) for $3.2 billion. Flow is widely recognized for his leadership and expertise in building and operating cannabis cultivation facilities.

Director Matt Kowalski has a tremendous amount of experience in the fruit and vegetable and biologics industries. Under his leadership at Natural Industries, a business focused on biological pest control, the company was awarded five EPA registrations: three biofungicides, a bionematicide, and a bioinsecticide. In November 2012, Kowalski led the strategic sale of Natural Industries to Novozymes BioAg. He is the principal owner of Stronghold Keep Inc., an investment corporation.

CFO Todd Lahti has extensive experience evaluating and managing start-up companies in the biotechnology, agricultural and oil and gas sectors, working directly on financing transactions, mergers and acquisitions, corporate strategy, business development, technology transfer and operations set up. He is a Chartered Financial Analyst and a Chartered Professional Accountant.

Recent News

chart

Cool Events Inc. (RNWR)

The QualityStocks Daily Newsletter would like to spotlight Cool Events Inc. (RNWR).

Cool Events (OTC: RNWR) offers a variety of unique, experiential running and obstacle events that attract thousands of participants sharing a passion for running and helping others. To view the full article, visit: http://nnw.fm/Oi6Xf.

Cool Events Inc. (RNWR) offers an array of unique, experiential running and obstacle events that attract thousands of participants sharing a passion for running and helping others. The company produced over 120 events in 2018 under the banner of five successful brands and has already lined up venues for 2019.

Cool Events offers the following trademarked events throughout the nation, with each dedicated to raising funds for important charities: Blacklight Run, the largest glow powder run in the world; Bubble Run, the largest daytime 5K run in the country; Foam Glow, The largest nighttime glow run in the country and the world’s only glowing foam run; Blacklight Slide, the first and only close to five story high Glow-N-Dark water slide with neon glowing water; and Terrain Race, the nation’s fastest growing and industry leading obstacle course race for all ages and athletic abilities.

Cool Events dedicates each of its trademarked runs and events to childhood cancer awareness, making sure this critically important issue is spread throughout the nation one runner, one race at a time. Since its first event in August 2013, the company has donated more than $1 million to Phoenix Children’s Hospital/Children’s Miracle Network and hundreds of thousands more to other charity partners such as Ronald McDonald House Charities of New Mexico, Make-a-Wish Foundation, Adoption Awareness, Special Olympics Massachusetts, St. Jude Children’s Research Hospital, Kendra’s Kisses, Boys and Girls Club and many more over the years.

Cool Events brings a seasoned management team with 35 years of combined experience in operating experiential events including obstacle course races, running races, experiential family events and other competitive events. The Cool Events team also offers consulting, marketing and development for outside events. The company’s in-house marketing agency can handle all brand awareness for event strategy, bringing an event’s vision and goals to life.

Cool Events Inc. (RNWR), closed the day's trading session at $0.11, up 10.00%, on 235,711 volume with 29 trades. The average volume for the last 3 months is 26,396 and the stock's 52-week low/high is $0.002/$0.231.

Recent News

chart

Plus Products Inc. (CSE: PLUS) (OTC: PLPRF)

The QualityStocks Daily Newsletter would like to spotlight Plus Products Inc. (CSE: PLUS) (OTC: PLPRF).

Plus Products Inc. (CSE: PLUS) (OTCQB:PLPRF) (the “Company” or “PLUS™”) is pleased to announce its participation in the newly formed National Cannabis Roundtable (“NCR”), a campaign aimed at reforming federal cannabis laws. The NCR will focus on advocating for a rational legal framework for cannabis reform in the United States. Former Speaker of the House, John Boehner, will serve as Honorary Chairman.

Plus Products Inc. (CSE: PLUS) (OTC: PLPRF) is a branded cannabis-infused products manufacturer of edibles created to support a healthy and active lifestyle. Headquartered in San Mateo, California, PLUS™ concentrates on producing edibles using extracts to ensure compliant, dosable and delicious products that provide a consistent cannabis experience.

First introduced to the market in 2015 to rave reviews, PLUS™ is now one of the top best-selling edible brands in California. PLUS™ operates through a wholly owned subsidiary, Carberry, and has four cannabis-infused gummy candy SKUs (in addition to limited edition SKUs), that are currently sold in over 200 licensed dispensaries and delivery services. All products under the PLUS™ brand are produced in the company’s 12,000-square-foot food-safe cannabis manufacturing facility in Adelanto, California.

PLUS Products shares are currently listed on the Canadian Securities Exchange. PLUS™ raised CAD$20 million through the offering, for which the lead underwriters were PI Financial and Canaccord Genuity. The company intends to use a portion of the IPO proceeds to fund rapid product capacity expansion, factory automation, working capital and new product development.

Operating in the largest adult-use recreational market in the U.S., PLUS Products holds a temporary manufacturing license in California and was one of the first brands to bring fully compliant products to the legal market. California legalized adult use recreational sales on Jan. 1, 2018, and industry analysts expect edible sales there will continue to amass enviable revenues. According to BDS Analytics, edibles made up 18 percent of marijuana retail sales in February 2018 across licensed retailers in California, with PLUS™ products ranking in the Top 10 of edible brands by retail dollar sales.

During the first half of 2018, PLUS Products generated US$2.45 million in sales, a marked improvement over 2017’s US$1.07 million in sales. The company’s established cannabis products are not only compliant with state laws, they are proving to be extremely popular with consumers. Among the PLUS™ product brands are:

  • Blackberry & Lemon RESTORE, an infusion of carefully dosed cannabis with a 9:1 THC to CBD per gummy.
  • Sour Watermelon UPLIFT, a low-calorie gummy crafted from carefully dosed cannabis with an infusion of 5mg THC per gummy.
  • Pineapple & Coconut CBD RELIEF, a tropical flavor gummy made from pure cannabis-derived CBD that is low-calorie, gluten-free and made with kosher ingredients.
  • Sour Blueberry CREATE, a low-calorie gummy infused with hybrid flower containing 5 mg THC.
  • Limited Edition Rose & Vanilla, available at select locations during Winter 2018, these gummies are crafted with 60 mg THC/30 mg CBD per tin.
  • Limited Edition RAINBOW SORBET gummies was created to celebrate Pride during Spring 2018 with a portion of each purchase donated to The Trevor Project, a confidential suicide hotline for LGBT youth.

“We are extremely proud of the products PLUS has brought to market,” remarked Jake Heimark, CEO and cofounder in a statement. “We’ve quickly grown into one of the leading edible brands in California. With the proceeds of this round, we will continue to further our mission: to make cannabis safe and approachable for all types of consumers.”

The PLUS™ team believes that everyone deserves access to consistent, dosable and delicious cannabis products and strives to make that happen. Producing the best infused products at scale requires thoughtful collaboration among experts in many fields. At PLUS™, our team is comprised of Chefs, Chemists, Food Manufacturing Experts, Engineers, Machinists, Visionaries, Creatives, Strategists and others.

Plus Products Inc. (PLPRF), closed the day's trading session at $5.7474, up 7.01%, on 272,687 volume with 925 trades. The average volume for the last 3 months is 128,294 and the stock's 52-week low/high is $2.81/$5.99.

Recent News

chart

ChineseInvestors.com (CIIX)

The QualityStocks Daily Newsletter would like to spotlight ChineseInvestors.com (CIIX).

ChineseInvestors.com, Inc. (OTCQB: CIIX) CEO Warren Wang discussed long-range plans to move to the NYSE or NASDAQ today on MoneyTV with Donald Baillargeon.

Founded in 1999, ChineseInvestors.com (CIIX) has become a leading financial information website for Chinese-speaking investors in the United States and China. Recognizing unprecedented opportunities in the U.S. cannabis industry, CIIX is also laying the groundwork to capitalize on growing demand for cannabidiol (CBD)-based nutrition and health products.

Through its primary website, www.ChineseInvestors.com, CIIX offers a variety of investor education products and services, including real-time market commentary, analysis and educational related services in Chinese language character sets; consultative services to smaller private companies considering becoming a public company; and advertising and public relations related support services.

At the center of this initiative is the ChineseInvestors Method, a unique integration of a disciplined investing process, web-based tools, personalized instructions and support. Using this strategy, CIIX provides reliable market information to help investors make informed investment decisions and meet their individualized financial goals.

CIIX is also leveraging its financial expertise to enter into the burgeoning CBD industry, which within a few years has grown from a relatively invisible sector to a billowing market expected to reach $2.1 billion in consumer sales by 2020.

The increasing demand for CBD-based products is a catalyst for innovative business endeavors. To this accord, CIIX has established a three-year development plan to capitalize on the convergence of CBD and the nutrition and health products market in mainland China, where the benefits of CBD oil have not been widely recognized.

Under a wholesale agreement with a reputable CBD health brand, CIIX is launching the world’s first online CBD health products store published in the Chinese language. The site, www.ChineseCBDoil.com, caters to a growing number of Chinese people awakening to the numerous health benefits of CBD oil for treatment of a variety of conditions such as anxiety, stress, poor sleep, Alzheimer’s disease, and more. CIIX expects to launch this website at the end of January 2017, and plans to sell CBD-infused products via online and in-store.

In conjunction, CIIX’s cannabis-focused “Yelp”-style mobile app is in development as a platform for Chinese people to review and discuss various cannabis products. The app will be the first marijuana social media mobile app designed for Chinese-speaking customers worldwide.

ChineseInvestors.com (CIIX), closed the day's trading session at $0.4799, up 2.11%, on 61,679 volume with 48 trades. The average volume for the last 3 months is 101,444 and the stock's 52-week low/high is $0.365/$1.25.

Recent News

chart

Green Hygienics Holdings Inc. (GRYN)

The QualityStocks Daily Newsletter would like to spotlight Green Hygienics Holdings Inc. (GRYN).

Full-scope, premium cannabis company Green Hygienics Holdings (OTCQB: GRYN) is poised to benefit from recent legislative changes in San Diego that could help it expand to the region, despite increased competition over cultivation land. To view the full article, visit: http://nnw.fm/0TyS6.

Green Hygienics Holdings Inc. (GRYN) is a full-scope, premium cannabis cultivation company targeting the high-end medical and adult-use recreational market. With more than 25 years of experience in agricultural science and innovation, Green Hygienics is establishing itself as a leader in the advancement of science-driven cannabis cultivation systems. The company will grow by generating revenues from the sales of premium grade cannabis products, developing and licensing valuable IP, making strategic acquisitions, and creating trusted global consumer brands.

The company has integrated and is developing its own IP assets related to proprietary systems and apparatus, software, algorithms and custom-engineered hardware. This provides ultimate efficiencies in a commercially controlled cultivation environment. Utilizing the advantages of hybrid-aeroponics, Green Hygienics creates a sterile growing environment that produces consistent, high-quality product while maintaining the lowest possible carbon footprint. The company utilizes state-of-the-art, quality-controlled commercial cultivation methodology to assure production of pharmaceutical-grade cannabis at much higher yields and greatly reduced costs.

Hybrid-aeroponics produces quality cannabis faster than traditional methods since it doesn’t require natural sunlight or soil and can be operational and produce plants anywhere. Plants grown under aeroponic conditions receive water and nutrients directly to their roots via a fine mist in a controlled environment, dramatically reducing spoilage while keeping the product organic and the environment pest-free. The plants are given the exact amount of nutrients and moisture precisely when needed. Green Hygienics maintains ultimate control over every aspect of this cultivation process, which allows the company to operate with conservation of natural resources in mind. The technology that uses 90-95 percent less water and does not require the use of pesticides or fungicides.

Additionally, the company’s state-of-the-art engineered, controlled environments include electrical, mechanical and HVAC designs that meet mandatory fire and energy codes while improving energy efficiency significantly.

Through these practices, Green Hygienics is establishing itself as a leader in the advancement of science-driven cannabis cultivation systems. The company continues to develop and incubate software as well as engineer hardware to provide additional control over the commercial cultivation method. The company’s science-based approach reveals any growth anomalies before the human eye can see them. This makes it possible to monitor all facets of production, identify cultivation problems based upon scientific data, and implement immediate corrective action, if needed.

The future of commercial cannabis cultivation hinges on using science to control the growing environment in order to remain competitive and deliver a premium grade of product on a consistent basis. The company holds a competitive advantage through its ability to produce premium cannabis products at a significantly lower cost per gram than direct competitors and others in the cannabis industry.

Innovations within the sector that create efficiencies and successful brands will become highly valued. Green Hygienics and its forward-thinking management team are constantly studying the market dynamics of the cannabis industry in North America and abroad while actively pursuing possible expansion opportunities. The company is headquartered in Las Vegas, Nevada and establishing operations in San Diego, California, targeting the $5 billion California cannabis market.

Green Hygienics Holdings Inc. (GRYN), closed the day's trading session at $0.518, up 5.71%, on 845 volume with 3 trades. The average volume for the last 3 months is 14,534 and the stock's 52-week low/high is $0.035/$0.579.

Recent News

chart

Pacific Rim Cobalt Corp. (CSE: BOLT) (OTCQB: PCRCF) (XFRA: NXFE)

The QualityStocks Daily Newsletter would like to spotlight Pacific Rim Cobalt Corp. (OTCQB: PCRCF).

Pacific Rim Cobalt Corp. (CSE: BOLT) (FRANKFURT: NXFE) announces that it has arranged a non-brokered private placement (the “Offering”) of up to 10,541,667 units (each a “Unit”) at $0.12 per Unit for gross proceeds of up to $1,265,000. The Company intends to use the net proceeds from the Offering for drilling and exploration, metallurgy and processing testing, and general working capital purposes. The Company may pay certain finders a fee for introducing eligible participants to the Offering.

Pacific Rim Cobalt Corp. (CSE: BOLT) (OTCQB: PCRCF) (XFRA: NXFE) is a Canada-based exploration company focused on the acquisition and development of production-grade cobalt deposits, a key raw material input for the growing lithium-ion battery industry.

Pacific Rim Cobalt and its Cyclops Nickel-Cobalt Project, located in the Depapre District, Jayapura Regency, Papua Province, Republic of Indonesia, is uniquely positioned in a region with potentially the largest source of cobalt outside of Africa. Strategically located near China, the world’s largest cobalt buyer, the Cyclops Project is a laterite (iron-hosted) mineral prospect, rich in cobalt and nickel. Cobalt consumption in China is on-track to use over 8,000 tonnes of cobalt annually by 2021 for electric vehicle production alone and is projected to remain the world’s largest cobalt consumer for many years to come.

Global demand for renewable power is fueling a massive shift from traditional energy supply chain economics to cobalt-reliant lithium-ion batteries, the world’s most widely used power source for portable applications such as electric vehicles and other high-tech applications.

Pacific Rim Cobalt management has concluded that strategic access to major markets offers the most important factor to servicing the rising demand for cobalt. The company’s acquisition of its initial asset in Indonesia offers near surface, strong nickel-cobalt mineralization in an area with excellent infrastructure including a nearby workforce, supplies, sealed roads, ocean access, nearby port facility and gentle topography. The project area, nestled on the north coast of Papua, Indonesia, establishes Pacific Rim Cobalt well within the economically attractive ocean-going transportation range to Asia and its lucrative, growing industrial markets.

Exploration efforts are currently focused on establishing a maiden compliant resource for the Cyclops project, both in historically identified and drill-tested prospects as well as previously unexplored areas of the claims. During the first nine months of 2018, the company focused on assembling the necessary agreements to access northern areas of the project hosting historically identified mineralized zones. Mapping, sampling and a mini-bulk sample within the mineralized zones has been completed, along with a small-scale program in the previously unexplored far southern area of the project. With surface access to priority targets now established, Pacific Rim Cobalt will initiate drilling and extract additional mini-bulk samples for further metallurgical testing.

“We are excited and optimistic about the unique possibility of developing this project into an asset that will add shareholder value and position the company to play a future role in the battery metals supply chain,” Pacific Rim Cobalt CEO Ranjeet Sundher recently stated (http://nnw.fm/u1HNs). “We expect the near-surface nature of cobalt/nickel mineralization at the Cyclops project will lend itself well to low-cost, logistically straightforward drilling. We thus anticipate the opportunity to undertake a resource calculation study, as well as ongoing metallurgy and process option testing, will present itself in the near future. It’s going to be a busy year ahead, and we look forward to getting the drills turning and building value.”

Pacific Rim Cobalt’s world-class management team includes Sundher, who has over 20 years of capital markets experience. Sundher is also president of Canrim Ventures Ltd., a Singaporean advisory firm specializing in early stage project finance and structure. He previously founded Indogold Exploration, a Jakarta-based mining service firm, and has raised over $40 million for companies in which he was a founder/partner.

Chief Financial Officer Steve Vanry has 25 years of professional experience in senior management positions with public and private natural resources companies, providing expertise in capital markets corporate finance, mergers and acquisitions, regulatory compliance, accounting and financial reporting.

Andre Talaska serves as country manager and technical supervisor. He has over 30 years of experience in the mining and exploration industry and has held senior positions with several companies in Australia and southeast Asia. Shakir Juffry, business development/engineering, is a chemical engineer and extractive metallurgist by background training who has over 20 years of experience in the Indonesian mining and minerals exploration field. Toto Suarto Sajali, operation and development manager, is a mining engineer with over 15 years of experience in Indonesian project assessment, development and operations.

Pacific Rim Cobalt Corp. (OTCQB: PCRCF), closed the day's trading session at $0.136063, up 4.66%, on 14,046 volume with 11 trades. The average volume for the last 3 months is 21,463 and the stock's 52-week low/high is $0.0701/$0.597.

Recent News

chart

BriaCell Therapeutics Corp. (OTC: BCTXF) (TSX.V: BCT)

The QualityStocks Daily Newsletter would like to spotlight BriaCell Therapeutics Corp. (BCTXF).

BriaCell Therapeutics (OTCQB: BCTXF) (TSX.V: BCT), a biotechnology company focused on immuno-oncology, is currently developing immunotherapy solutions demonstrated to be highly effective and well tolerated by patients. To view the full article, visit: http://nnw.fm/O6Iu7.

BriaCell Therapeutics Corp. (OTC: BCTXF) (TSX.V: BCT), based in Berkeley, CA, and headquartered in Vancouver, British Columbia, is a clinical-stage biotechnology company focused on the development of targeted immunotherapy for advanced breast cancer.

BriaCell hopes to develop and market the first off-the-shelf personalized immunotherapy for the treatment of advanced breast cancer.

The results of two previous proof-of-concept clinical trials produced encouraging results in patients with advanced breast cancer. Most notably, one patient with breast cancer that had spread to other sites (metastatic cancer) responded to Bria-IMT™ with a substantial tumor shrinkage in multiple sites including the breast, the lung, soft tissues and even the brain. Similar observations have been confirmed more recently in additional patients, and BriaCell is developing BriaDX™ as a way to identify those patients most likely to respond.

BriaCell has recently completed recruitment of a Phase I/II study (NCT03066947) of Bria-IMT™, the Company’s lead product candidate, in advanced breast cancer patients showing an outstanding safety profile and excellent efficacy. BriaCell is currently enrolling advanced breast cancer patients in a combination therapy trial (NCT03328026) of Bria-IMT™ with Keytruda® (Keytruda® is a registered trademark of Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.) or Yervoy® (Yervoy® is a registered trademark of Bristol-Myers Squibb Company). For further information on the Phase IIa clinical trials, please visit trial NCT03066947 and trial NCT03328026.

BriaCell’s pipeline also includes Bria-OTS™, the first off-the-shelf personalized immunotherapy for advanced breast cancer; and, a companion diagnostic product BriaDX™. By using BriaDX™ to identify and treat the patients who would most likely benefit from their immunotherapies, BriaCell expects to personalize the treatment for the patients, and bring hope to thousands of cancer patients who currently have few-to-no treatment options.

Breast Cancer Statistics

The National Cancer Institute estimates that more than 265,000 new cases of female breast cancer will be diagnosed in the U.S. during 2018, and that more than 40,000 women in the U.S. will die from the disease. Approximately 12 percent of women will be diagnosed with breast cancer at some point during their lifetime, based on 2013-2015 data.

Using its novel technology platform and strong R&D capabilities, BriaCell believes it has the opportunity to address this market, as well as have the opportunity to develop immunotherapy candidates for other cancer indications.

The global cancer immunotherapy market is expected to reach nearly USD$203 billion by 2025.

BriaCell Therapeutics Corp. (BCTXF), closed the day's trading session at $0.069, up 12.80%, on 20,450 volume with 2 trades. The average volume for the last 3 months is 17,062 and the stock's 52-week low/high is $0.0495/$0.135.

Recent News

chart

SinglePoint, Inc. (SING)

The QualityStocks Daily Newsletter would like to spotlight SinglePoint, Inc. (SING).

Technology and investment company SinglePoint (OTCQB: SING) was featured on this week’s episode of MoneyTV with Donald Baillargeon. To view the full interview, visit: http://nnw.fm/a7fNj. To view the full press release, visit: http://nnw.fm/5sQIT.

SinglePoint, Inc. (SING) is a diversified holding company with operations in multiple industries and verticals including two high-performing market sectors: legal cannabis and cryptocurrencies. SinglePoint has grown from a full-service mobile technology provider to a recognizable brand with a diverse portfolio of undervalued subsidiaries with multiple revenue streams.

SinglePoint is researching opportunities where it can be an active participant by influencing the strategy and direction of high-potential companies whose verified assets offer attractive possibilities for shareholders. The company is guided by a visionary leadership team with extensive experience in technology, engineering, marketing and raising capital.

SinglePoint is bullish on the cannabis industry, bitcoin and blockchain technologies, which is evident in its recent acquisitions and joint-venture announcements. Recent SinglePoint key highlights include:

  • A joint venture with Smart Cannabis Corporation (OTC: SCNA) to license and market Smart Cannabis’ SMART APP. SMART APP enables cannabis growers to measure all aspects of cultivation, from soil nutrient levels to watering cycles and carbon dioxide content in the air. SMART APP will integrate SinglePoint’s bitcoin payment solution to enable growers to process safer and more secure transactions.
  • A joint venture with Global Payout (OTC: GOHE) will build on existing financial technology solutions developed by SinglePoint and Global Payout’s subsidiary MoneyTrac Technology, Inc., to fully optimize the delivery of mobile payment applications for domestic and international organizations.
  • A joint venture with AppSwarm (OTC: SWRM) to start development on a proprietary delivery application that will enable licensed cannabis delivery services and licensed dispensaries to safely make in-home cannabis deliveries.
  • Signed original “Shark Tank” member Kevin Harrington as company spokesman for an innovative, compatible virtual wallet to store any type of cryptocurrency. Harrington recently finished shooting a new national ad campaign featuring SinglePoint and the virtual wallet’s secure method of storing cryptocurrencies.
  • Entered into a letter of intent to acquire 100 percent of Bitcoin Beyond, a premier platform that enables merchants to accept bitcoin payments using existing web-enabled point-of-sale devices.
  • Through SING subsidiary, SingleSeed, the company will soon offer a proprietary cryptocurrency solution that links both cannabis merchants and consumers who seek to take advantage of bitcoin-powered transactions using debit and credit cards. In addition to making bitcoin-backed card purchases possible, the solution enables cannabis dispensaries to digitally track and manage their product inventories, performing tasks like uploading product data, photos and descriptions. The system deducts items automatically from a dispensary’s product listings when a purchase is made. While this fully KYC-AML compliant point-of-sale platform can be utilized for any other retail setting, it will fill a critical need in the underbanked cannabis industry as it continues to seek non-cash payment solutions outside of traditional banking circles.

SinglePoint CEO and founder Greg Lambrecht leads the company in its mission to capture opportunities through an aggressive expansion strategy across a broad range of assets. Lambrecht oversees all company operations including investor relations, leadership of the board of directors, and daily business activities. As the founder of PCI, a leading consumer product distribution company, Lambrecht negotiated agreements with the nation’s largest retail outlets and led PCI through a NASDAQ listed IPO, raising $10 million.

Eric Lofdahl, SinglePoint’s chief technology officer, has more than 20 years of experience in the technology sector including positions in software development, program management, complex system integration and engineering process definition. Prior to SinglePoint, Lofdahl worked at the Boeing Company where he led a team that successfully developed advanced wireless and satellite data products based on commercial technology for the U.S. Air Force.

SinglePoint President Wil Ralston is well known for his successful track record of building and maintaining great relationships with clients. Ralston graduated cum laude from the WP Carey School of Business at Arizona State University with a degree in Global Agribusiness and a specialization in Professional Golf Management. He is currently recognized by the Professional Golfers Association of America (PGA) as a Class A Professional.

SinglePoint, Inc. (SING), closed the day's trading session at $0.01934, up 0.21%, on 3,618,842 volume with 156 trades. The average volume for the last 3 months is 6,149,486 and the stock's 52-week low/high is $0.0106/$0.0776.

Recent News

chart

Icon Exploration Inc. (TSX.V: IEX.H)

The QualityStocks Daily Newsletter would like to spotlight Icon Exploration Inc. (IEX.H).

After careful consideration, Icon Exploration (TSX.V: IEX.H) CEO Rob Fia selected City View Green ("CVG"), a vertically integrated cannabis company incorporated under the laws of Ontario, Canada, as its acquisition target. To view the full article, visit: http://nnw.fm/wMqK5.

Icon Exploration Inc.'s (TSX.V: IEX.H) primary objective is to create a well-diversified company focused on assessing and potentially acquiring targets in the cannabis industry. Icon Exploration recently signed a formal share exchange agreement relating to its proposed acquisition of privately held City View Green (“CVG”), a vertically integrated cannabis company incorporated under the laws of Ontario, Canada. CVG’s application to Health Canada for an Access to Cannabis for Medical Purposes Regulations (“ACMPR”) license is now at the in-depth review stage of the licensing process.

CVG is preparing a 40,000-square-foot growing facility near Toronto to produce pharmaceutical-grade cannabis once its ACMPR license is granted. About half of the facility will initially be outfitted with state-of-the-art LED lighting, HVAC and dehumidification systems, and automation technologies to optimize the quality, safety and consistency of cannabis production. About 4,000 square feet will be devoted to an extraction laboratory featuring an ultra-efficient CO2 supercritical extraction process with plans to include ethanol extraction technology in the future.

Another 4.3 acres remains available for future construction of up to 125,000 square feet of grow and extraction space. Production plans include producing high quality edible products, distillates, and water-soluble products for the rapidly expanding CBD-infused (cannabidiol) beverage market.

Management

Icon and CVG have assembled a talented team that includes a Master Grower with cannabis-industry experience to manage indoor grow operations and an extraction expert whose expertise in developing and launching new products was honed while working in Washington state’s cannabis sector. Having gained experience in the Washington state market the extraction expert has a number of brand ideas and recreational cannabis products that became popular in the Washington market as well as a number of in-licensing branding opportunities available to CVG. CVG has also negotiated an agreement with a private company seeking 37 retail cannabis licenses in Alberta, Canada, that provides a reciprocal exchange of shares, product, shelf space and distribution lines. Early discussions with various entities in Europe to arrange an off-take agreement for CBD oils and extracts are also underway.

Market Opportunity

The Canadian medical cannabis market has steadily been growing with an average 10 percent increase in patients each month. Now that the Canadian federal government has legalized recreational cannabis for adult users nationwide, analysts project a compound annual growth rate of nearly 78 percent from 2018 to 2021, reaching an estimated $3 billion by 2021, ArcView Market Research reports. One study from Deloitte pegged the potential economic impact of legalized medical and recreational marijuana in Canada – including transportation, licensing fees and security – at more than $22 billion over the coming years. Health Canada’s most recent data show that sales of cannabis extracts grew 961 percent in the second quarter of 2017, compared to an 89 percent increase in growth of dried cannabis during the same period.

Icon Exploration Inc. (TSX.V: IEX.H), closed the day's trading session at $0.41, even for the day.

Recent News

chart

Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF)

The QualityStocks Daily Newsletter would like to spotlight Green Growth Brands Inc. (OTCQB: GGBXF).

Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) was highlighted today in a publication from Investorideas.com, which is essentially a snapshot reporting on the burgeoning CBD market, where branding increasingly becomes essential to companies hoping to stand out. Also today, the company was featured in the 420 with CNW by CannabisNewsWire, looking at how Circuit Court Judge, Karen Gievers, has ruled that the state and the health department in Florida violated the constitution when they imposed a cap on the number of dispensaries that a licensed business could open within the state.

Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) is a lifestyle-oriented cannabis and cannabidiol (“CBD”) consumer products company with a portfolio of lifestyle brands customized to connect specific, like-minded customers. Each Green Growth Brand provides the best quality products within a retail experience that appeals to users in an environment that is emotionally branded and easy to navigate.

In the next five years, the cannabis industry will generate more than $28 billion of new revenue from an estimated 14 million new customers, according to Ackrell Capital’s 2018 Cannabis Investment Report. Meanwhile, Hemp Business Journal projects that the CBD market will increase 8x to $3 billion by 2021, up from $200 million in 2017. Green Growth Brand intends to dominate in these markets with a lineup up products grown, manufactured and presented with the highest quality standards in mind.

Products under the Green Growth Brand umbrella include:

  • CAMP: A kiosk-type store where consumers can experience beautifully crafted lifestyle products that enhance one’s journey to self-discovery.
  • Seventh Sense: A CBD-infused body care collection crafted from the finest botanicals and fragrances on earth. Created to maximize the properties and aromatics of each ingredient, Seventh Sense natural products are CBD-infused botanical therapy.
  • Meri+Jayne: Fiercely authentic and wholly unapologetic, Meri+Jayne is a youthful, full-on celebration of what makes each person unique. Expect the unexpected when it comes to this mix of amazing products.
  • Green Lily: A place for women to explore a new world of wellness. With advice on every product, from efficacy to usage, Green Lily guides guests through beautiful new ways to experience cannabis and CBD.
  • The +Source: Located in Las Vegas and Henderson, Nevada, The+Source dispensaries operated by Green Growth Brands serve both medical patients and retail customers. Green Growth Brands also operates a grow and production facility in Post, Nevada, and recently entered into definitive agreements to acquire a Pahrump, Nevada, cultivation facility.
  • XanthicBiopharms is the owner of valuable intellectual property that turns THC(Tetrahydrocannabinol) and CBD into a water-soluble substance. As a result of combining Green Growth Brands and Xanthic, this technology is being used to create incredible new products.

Business Strategy

Green Growth Brands has identified numeroushitches in the current cannabis retail space. The company intends to counter these challenges and provide a customer experience ripe with a friendly staff, in-stock assortments, efficient operations and more. The company’s retail partners provide distribution opportunities within 4,000 stores, as well as robust and established digital platforms to best reach the modern consumer.

Management

Green Growth Brands brings together a collection of expert retailers, scientists, botanists, developers, artists and business leaders for the benefit of building community. Led by an executive management team steeped in decades of experience with several of America’s most successful brands, including Victoria’s Secret, American Eagle Outfitters, Bath & Body Works, Limited Brands and Designer Shoe Warehouse, Green Growth Brands is uniquely positioned to create memorable brands, retail experiences, and quality products for the emerging cannabis industry.

Chief Executive Officer Peter Horvath heads strategy and execution across all company channels, and previously took shoe retailer DSW public on the NYSE at $1.5 billion. As a dynamic, creative brand leader, team builder, and specialty retail veteran with deep roots in finance, Horvath’s unique ability to understand the big picture while never missing the subtle details is a critical factor in Green Growth Brands’ success and brand popularity among customers.

Chief Marketing Officer Scott Razek is a brand strategist, storyteller and strategic marketer. Razek‘s 25 years of experience in brand building, product development and customer experience focus are a key differentiator for the Green Growth Brands portfolio.

CAO Ed Kistner brings 33 years of multifaceted experience at leading retail businesses, notably in finance, merchandise planning, operations and stores. His well-rounded experiences in fast-changing environments position Kistner to be the architect of the operational execution at Green Growth Brands.

CSO Kellie Wurtzman brings significant retail leadership to Green Growth Brands with a proven track record of leading high-performance stores and teams across multiple retail sectors. Her unmatched experience in identifying and supporting developing business opportunities is ideal for evolving the cannabis industry and will be instrumental in expanding operations at Green Growth Brands.

Headquartered in Columbus, Ohio, Green Growth Brands is traded on the Canadian Securities Exchange and on the OTCQB, providing investors with increased access to data, transparency and liquidity.

Green Growth Brands Inc. (OTCQB: GGBXF), closed the day's trading session at $4.3381, off by 2.30%, on 219,508 volume with 530 trades. The average volume for the last 3 months is 185,754 and the stock's 52-week low/high is $1.8068/$5.205.

Recent News

chart

TransCanna Holdings Inc. (CSE: TCAN)

The QualityStocks Daily Newsletter would like to spotlight TransCanna Holdings Inc. (CSE: TCAN).

TransCanna Holdings (CSE: TCAN) (FSE: TH8) today announced that in addition to the branding and marketing business of Goodfellas Group, LLC, subject to completion of the previously-announced acquisition, the company will acquire its existing in-house brand "Simple". To view the full press release, visit: http://nnw.fm/D7mif.

TransCanna Holdings Inc. (CSE: TCAN) through its subsidiaries specializes in assisting clients who are cannabis farmers and manufacturers get recognized by end consumers who in turn purchase their products. TransCanna offers or will be offering services to support almost every aspect of the cannabis-related eco-system; from branding and design, to transportation and distribution, to marketing and sales.

California’s legalized adult-use recreational marijuana market opened for business January 1, 2018. The state’s Bureau of Cannabis Control is responsible for regulating all commercial activities in the state including cultivation, distribution and transportation. Moving cannabis products in the California marketplace is extremely challenging due to municipal and state laws and regulations, which can differ among cities and counties. Since cannabis remains illegal under federal law, Department of Transportation regulated companies are barred from participating in the market, which means companies looking to excel in the sector must hold a state-issued distributor license from the Bureau of Cannabis Control.

TransCanna has already entered into an Intellectual Property Rights and Royalty Agreement for the Track & Trace software platform required by the state of California. TCM Distribution, the operating company managed by TransCanna, has received a transportation and distribution permit from the city of Adelanto and a temporary transportation and distribution permit from the state of California. TransCanna has also executed a land lease to build a 10,000-square-foot transportation and distribution facility in Adelanto.

TransCanna is strategically creating a distribution network throughout California that places its facilities no further than a three-hour drive from most any client. The company is in the process of leasing or purchasing properly licensed and permitted warehouses strategically located throughout California along with new secure trucks, sprinter vans and/or armored vehicles.

TransCanna plans to create its own portfolio of branded products for the cannabis and hemp sectors. The company’s management team intends to translate the skills, knowledge and experience gained from a combined 60 years of branding and marketing experience in the music, professional sports and alcohol industries into TransCanna and the cannabis industry.

As part of the “TransCanna Way,” the company intends to manage most aspects of the supply chain from upper end procurement, branding, transportation and distribution, to marketing and sales.

Leading TransCanna as its CEO and chairman is James Pakulis, who has three decades of experience working with public and private entrepreneurial companies in a variety of emerging and high-growth sectors. He is formerly the president and a director of Lifestyle Delivery Systems Inc. (CSE: LDS) (OTCQB: LDSYF), a vertically integrated cannabis-related entity operating in California. Pakulis was chairman and CEO of General Cannabis Inc. which from 2010 to 2012 owned WeedMaps. Pakulis oversaw the company’s growth from zero to over $16 million in annual revenue in less than 24 months.

The company’s strategic advisors include individuals with extensive experience in branding, marketing, sales, distribution, production and supply chain management.

For additional information, call: (604) 609-6199

TransCanna Holdings Inc. (CSE: TCAN), closed the day's trading session at $2.12, off by 5.78%, on 57,125 volume with 57 trades. The stock's 52-week low/high is $0.77/$2.59.

Recent News

chart

The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF)

The QualityStocks Daily Newsletter would like to spotlight The Green Organic Dutchman (OTC: TGODF).

Cannabis-focused research and development company The Green Organic Dutchman Holdings (TSX: TGOD) (OTCQX: TGODF) this morning announced that it has secured a cannabis supply agreement with the Ontario Cannabis Retail Corporation, which operates as the Ontario Cannabis Store ("OCS"). To view the full press release, visit: http://nnw.fm/7wCWQ. Also today, the company was highlighted in an article examining how two of the hottest sectors this year could be Tech and Cannabis.

The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF), whose principal location is in Hamilton, Ontario, produces farm grown, organic, pesticide-free medical cannabis in small batches using all natural, organic craft growing principles. TGOD is licensed under the Access to Cannabis for Medical Purposes Regulations (ACMPR) to cultivate medical cannabis. The company carries out its principal activities producing cannabis pursuant to the provisions of the ACMPR and the Controlled Drugs and Substances Act (Canada).

Committed to becoming the global leader in delivering organic cannabis solutions that enhance people’s lives, TGOD consistently adheres to the highest levels of excellence. Its world-class management team includes a proven group of leaders with outstanding executive and operational experience specific to consumer packaged goods, consumer products, cannabis and finance industries.

TGOD is positioned as one of the highest quality and most cost efficient cannabis producers in Canada by leveraging innovative technology and low-cost power solutions. It holds one of the largest land packages under a single ACMPR license in Canada, providing future cannabis Agri-park style development and opportunities for joint ventures, licensing and distribution partners. Its industry leading alliance partners include Eaton, Ledcor Group and Hamilton Utilities Corp.

Eaton is the second largest power management company in the world and promises to supply innovative and cost effective power solutions to meet TGOD’s growing demands. Construction management is supplied by Ledcor, Canada’s second largest multidisciplinary construction company and a pioneer in the Green Building Industry. An alliance with Hamilton Utilities Corp allows TGOD to reduce its power costs from $0.13 per kWh to less than $0.05 per kWh. Greenhouse design is provided by Larssen Greenhouse, whose 25-plus years of experience in building some of the most modern and sophisticated greenhouses in the industry will provide TGOD with state of the art, climate-controlled hybrid greenhouse solutions.

Canada is quickly becoming a hub for cannabis investors with over $1.3 billion raised by Canadian companies to date. There are 58 licensed producers to service a population of 36 million and only two organic producers. TGOD, which holds licenses in Ontario and Quebec, is strategically located in both provinces that together claim 22 million Canadians as residents. Another estimated 57 million people live next door in six U.S. bordering states.

The Canadian cannabis market currently has a massive supply demand gap, which makes TGOD’s expansion plans even more important to investors. These plans include a combined build-out capacity of 970,000 square feet, allowing TGOD to produce 116,000 kg annually of organic cannabis. Upon completion, Phase One in Hamilton, Ontario, which is fully funded, will provide 150,000 square feet of growing capacity capable of producing up to 14,000 kg of cannabis or $112 million in revenue at $8 a gram.

The company’s Quebec expansion will be constructed on a recently secured 75-acre property near Montreal. This new property has a planned expansion of 820,000 square feet capable of producing 102,000 kg of organic cannabis. The first phase of this expansion is underway and construction is expected to be completed by the end of 2018. Quebec’s first phase will consist of 220,000 square feet capable of producing 22,000 kg of cannabis. Two additional expansion phases will add 250,000 square feet (26,000 kg of cannabis) and 350,000 square feet (54,000 kg of cannabis). Power costs remain exceptionally low for both facilities with access to all other needed utilities available and close by.

TGOD also plans to gain a share of the burgeoning cannabis oils market which by Q1 2017 accounted for 49 percent of all cannabis sold in Canada under the ACMPR, up from only 27% in Q2 2016. TGOD has ordered a purpose-built extraction laboratory with an estimated commission in Q4 of 2017. This is a commercial-scale CO2 extraction unit capable of processing up to 12,000 kg of raw material per year and producing approximately $170 million worth of organic cannabis oils. Raw cannabis oil provides a significant downstream manufacturing opportunity into several potential recreational market verticals including edibles, beverages, topicals and concentrates.

Data from the Canadian ACMPR Market Trends report indicates a rising number of consumers will continue to seek out healthier, less conspicuous ways to consume cannabis, ensuring sales of organic cannabis oil products remain brisk. Organic cannabis products demand a significant premium compared to non-organic products and the demand keeps growing.

Plans to take the company public are underway with an initial public offering (IPO) slated for January 2018. In November, the company raised $13 million in equity financing and in March closed a $27 million non-brokered private placement. Another $20 million is currently being raised before the IPO in January, which will be utilized for expansion plans.

TGOD is uniquely positioned between the medical and recreational cannabis industry since Canada is scheduled to legalize cannabis for all adults in mid-2018. As of August 2017, TGOD has 2,400 shareholders. Established in 2012, TGOD’s motto, “Making Life Better,” can be seen in its strategic partnerships, top quality management team, and dedication to organic farming and principles.

To learn more about the company and how to invest, contact TGOD directly at financing@tgod.ca

The Green Organic Dutchman (OTC: TGODF), closed the day's trading session at $2.55, off by 1.45%, on 745,034 volume with 1,149 trades. The average volume for the last 3 months is 906,149 and the stock's 52-week low/high is $1.606/$7.89.

Recent News

chart

Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF)

The QualityStocks Daily Newsletter would like to spotlight Supreme Cannabis Company Inc. (OTC: SPRWF).

The Supreme Cannabis Company Inc. (TSX: FIRE) (OTC: SPRWF) (FRA: 53S1) has started trading on the Toronto Stock Exchange (“TSX”). Effective February 4, the company’s listed securities began trading under ticker symbols ‘FIRE’ and ‘FIRE.DB’ (http://nnw.fm/Wb8G4). Also today, approval from The Depository Trust Company ("DTC") of New York to make the Company's shares DTC eligible was announced. Additionally, the company was highlighted in a snapshot reporting on the CBD market examining how branding is more and more essential to companies hoping to stand out.

Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF), is committed to providing premium brands and products that reflect the company’s knowledgeable customers, passionate employees, and culture of innovation. Supreme Cannabis’ mission is to grow the world’s best cannabis and become a leader in the global industry. The company calls its Toronto Venture Exchange stock symbol FIRE “a testament to our passion for cannabis and our obsession with quality.”

Supreme Cannabis believes the world is ready to follow Canada’s lead by ending the 100-year cannabis prohibition and, as Canada’s only coast-to-coast premium cannabis producer, the company sees itself at the center of this global shift.

In August 2018, Supreme Cannabis uplisted its shares to the to OTCQX market in the U.S., where the company trades under the ticker symbol SPRWF. The following month Supreme reported record Q4 revenues of CAD$3.55 million, a 71-percent increase over the previous quarter. Supreme Cannabis also recorded revenue of CAD$8.85 million for its fiscal year ended June 30, 2018, placing it among publicly traded Canadian cannabis companies with the highest reported revenue in their first four quarters of sales.

“As a result of the successful execution of our strategy, we have generated significant revenue growth both for the quarter and the year-end period,” Supreme Cannabis CEO Navdeep Dhaliwal stated in a news release. “We look forward to building on this growth as we expand domestically and internationally.”

The company’s growth strategy includes key industry agreements, such as its CAD$12 million supply agreement with Tilray Inc. (OTC: TLRY), a global leader in cannabis research, cultivation, processing and distribution. The agreement calls for Supreme to supply Tilray with dried cannabis for support of medical cannabis patients in Canada for the period of one year.

Another key component is the company’s wholly owned 7ACRES subsidiary. The 7ACRES cultivation facility, one of the first 40 federally licensed cannabis producers in Canada, is focused on building a core competency in scaled cannabis production, which will give 7ACRES the needed flexibility to maintain leadership in the industry as the Canadian market grows and matures. Though 7ACRES is Supreme Cannabis’ flagship brand and only currently operating business unit, the company will continue to identify new opportunities to grow its portfolio of companies and build innovative cannabis businesses throughout the world.

7ACRES operates from a 342,000-square-foot cultivation facility in Kincardine, Ontario, and has been federally licensed since 2016. Current capacity is 13,333 kilograms dried cannabis annually, with plans to ramp up production by mid-2019 to a rate of 50,000 kilograms per year.

Supreme Cannabis seeks to differentiate 7ACRES from other licensed cannabis producers by producing premium quality product sustainably at scale. “Craft quality, commercial scale” is a slogan the company uses, and the Kincardine greenhouse employs state-of-the-art technology and cultivation best practices to strive toward that goal. Supreme identifies the quality of the 7ACRES product as the company’s primary strength and says a shared “passion for the plant” is the driver of company culture. Six Canadian provinces have signed supply agreements with Supreme, a fact the company credits to the high quality of 7ACRES cannabis.

Its customers, Supreme Cannabis management says, are informed and discerning regarding cannabis, and they value a premium brand that respects their product knowledge. The company believes its high regard for customers, premium product quality, and mass cultivation capability has allowed Supreme Cannabis to emerge as Canada’s preeminent premium cannabis producer. In the Canadian cannabis market, the company has established 7ACRES as a premium brand that’s distributed coast-to-coast and commands premium pricing. The 7ACRES brand is already listed as premium cannabis product in all provinces that disclose their cannabis listing categories, and 7ACRES on average wholesales for up to one-third higher in price than other brands in the Canadian cannabis market.

To further its distribution, in the medical cannabis market Supreme Cannabis has partnered with several Canadian cannabis retailers including Aurora Cannabis, Emerald Health Botanicals, Namaste, Zenabis, and others. The company’s investment portfolio also includes an equity position and long-term global distribution partnership with Medigrow, based in Lesotho, targeting the export of medical cannabis oil for the international market.

Supreme Cannabis seeks to make the company an innovator in the cannabis sector regarding design of cultivation facilities and development of operation excellence metrics. The management team is confident that the 7ACRES flagship brand, the company’s proprietary technology and products, and the company’s culture of passion for cannabis will deliver consistent long-term shareholder value.

Supreme Cannabis Company Inc. (OTC: SPRWF), closed the day's trading session at $1.46, off by 11.52%, on 1,459,218 volume with 1,100 trades. The average volume for the last 3 months is 402,545 and the stock's 52-week low/high is $0.85/$2.04.

Recent News

chart

Golden Developing Solutions, Inc. (DVLP)

The QualityStocks Daily Newsletter would like to spotlight Golden Developing Solutions, Inc. (DVLP).

Golden Developing Solutions, Inc. (DVLP) was highlighted today in 420 with CNW by CannabisNewsWire discussing how Circuit Court Judge, Karen Gievers, has ruled that the state and the health department in Florida violated the constitution when they imposed a cap on the number of dispensaries that a licensed business could open within the state.

Golden Developing Solutions, Inc. (DVLP), an emerging leader in ancillary software and the cannabidiol (CBD) products marketplace, provides business services and/or products supporting the cannabis industry including an online retail business for CBD, hemp oil and health/wellness related products.

Global acceptance of cannabis and related CBD products continues to increase as North America advances toward favorable legislation. Canada legalized recreational cannabis in October 2018, and the United States has 30 states and the District of Columbia allowing either recreational or medical cannabis, or both. Voters in four additional U.S. states will consider marijuana initiatives on the November 2018 ballot. The global legal cannabis market is projected to reach USD$146 billion by the end of 2025, with a greater acceptance of medical cannabis products as a driving factor, according to Grand View Research.

DVLP is taking advantage of consumer demand for CBD products through its wholly owned Pura Vida Vitamins, LLC subsidiary, which recently launched a direct-to-consumer website (www.PuraVidaVitamins.com) and commenced sales of Pura Vida branded products. Pura Vida merchandise includes hemp and CBD-related products and other products focusing on health and lifestyle which are available through established wholesale and distribution channels. In addition, a line of CBD pet supplements and other products are in development.

DVLP recently acquired “Where’s Weed” (Layer Six Media LLC DBA “Where’s Weed”) and its primary asset, WheresWeed.com. Where’s Weed is an American cannabis technology company known for connecting medical and recreational cannabis users with trusted local marijuana businesses in their communities. As a rapidly growing community-based online resource for cannabis consumers with a host of user-friendly services, Where’s Weed offers a sophisticated mobile app with strong traction and powerful growth potential as the North American legal cannabis market continues to expand exponentially.

WheresWeed.com has a large and expanding reach with nearly 3 million pageviews per month. In addition, the WheresWeed mobile app, available in both iOS and Android, has been downloaded over 80,000 times, proving to be complementary to DVLP’s objective to capitalize on the massive growth curve in the marijuana space.

“The huge flood of new growers and producers is likely to create oversupply in the near term, narrowing margins for major producers,” says DVLP CEO Stavros Triant. “However, this should actually increase the net number of new consumers in the marketplace, further reinforcing the enormous growth potential for hub service providers in the space that are situated on high-traffic internet real estate, which is exactly how we view the Where’s Weed property.”

The company’s move into the lucrative C-store snack market was solidified with a material purchase order for CBD oils from a major distributor specializing in the snack foods and accessories to the convenience store and gas station market. The order represents significant progress as DVLP gears up its ready-made snack distribution strategy for its CBD products.

“We are extremely excited about the launch of our CBD product line with this distributor,” Triant states. “The C-Store strategy dovetails perfectly with our direct marketing strategy through our primary online retail channel, and we have indications from the distributor that, if this initial test order goes well, successive Purchase Orders could be significant and underpin strong sales growth in Q1 2019.”

Golden Developing Solutions, Inc. (DVLP), closed the day's trading session at $0.019975, off by 0.12%, on 6,952,062 volume with 218 trades. The average volume for the last 3 months is 543,823 and the stock's 52-week low/high is $0.0122/$0.14.

Recent News

chart

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

ActionStockPicksAgressive StocksBetting On Wall StreetCannabisNewsWireGot Stocks?Got Stock Tips?Green Car StocksGreen Energy StocksGreen On The StreetHomeRunStocksMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireQualityStocks MediaQStocksQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsStock BeatsStocks To Buy NowTerrificStocksTiny GemsTip.usTouchdownStocksDaily ToutTraderPower

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.